CTNNA2 and neoplasm: To confirm CTNNA2 mediated angiogenesis inhibition in vivo, we performed CD31/PECAM-1 (Platelet Endothelial Cell Adhesion Molecule-1) immunohistochemical staining on tumor sections from mice and counted the blood vessels.